CHH · Class I · 21 CFR 862.1175

FDA Product Code CHH: Enzymatic Esterase--oxidase, Cholesterol

Leading manufacturers include Medicon Hellas S.A and Truvian Health.

230
Total
230
Cleared
87d
Avg days
1976
Since
Growing category - 2 submissions in the last 2 years vs 1 in the prior period
Review times increasing: avg 315d recently vs 85d historically

FDA 510(k) Cleared Enzymatic Esterase--oxidase, Cholesterol Devices (Product Code CHH)

230 devices
1–24 of 230

About Product Code CHH - Regulatory Context

510(k) Submission Activity

230 total 510(k) submissions under product code CHH since 1976, with 230 receiving FDA clearance (average review time: 87 days).

Submission volume has increased in recent years - 2 submissions in the last 24 months compared to 1 in the prior period - suggesting growing market activity in this device classification.

FDA Review Time

Recent submissions under CHH have taken an average of 315 days to reach a decision - up from 85 days historically. Manufacturers should account for longer review timelines in current project planning.

CHH devices are reviewed by the Chemistry panel. Browse all Chemistry devices →